Christa L. Borgman

Integrative Genomic and Proteomic Analyses Identify Targets for Lkb1-Deficient Metastatic Lung Tumors

Julián Carretero, Takeshi Shimamura, Klarisa Rikova et al. · Cancer Cell · 2010 · 260 citations · Full text

Medicine, Molecular Biology, Oncology +16

Bronchial and Peripheral Murine Lung Carcinomas Induced by T790M-L858R Mutant EGFR Respond to HKI-272 and Rapamycin Combination Therapy

Danan Li, Takeshi Shimamura, Hongbin Ji et al. · Cancer Cell · 2007 · 235 citations · Full text

Medicine, Cancer Biology, Oncology +11

Inhibition of ALK, PI3K/MEK, and HSP90 in Murine Lung Adenocarcinoma Induced by <i>EML4-ALK</i> Fusion Oncogene

Zhao Chen, Takaaki Sasaki, Xiaohong Tan et al. · Cancer Research · 2010 · 191 citations · Full text

Medicine, Oncology, Pharmacology +17

HER2 ^YVMA drives rapid development of adenosquamous lung tumors in mice that are sensitive to BIBW2992 and rapamycin combination therapy

Samanthi A. Perera, Danan Li, Takeshi Shimamura et al. · Proceedings of the National Academy of Sciences · 2009 · 179 citations · Full text

Medicine, Cancer Biology, Pharmacology +17

Ganetespib (STA-9090), a Nongeldanamycin HSP90 Inhibitor, Has Potent Antitumor Activity in <i>In Vitro</i> and <i>In Vivo</i> Models of Non–Small Cell Lung Cancer

Takeshi Shimamura, Samanthi A. Perera, Kevin P. Foley et al. · Clinical Cancer Research · 2012 · 166 citations

Medicine, Oncology, Pharmacology +13